On a mission to 'unify' drug discovery and cell-line development, AbSci acquires AI outfit Denovium

Imagine discovering a drug and cell line at the click of a button. That’s the goal of AbSci CEO Sean McClain — and on Monday, he …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

On a mis­sion to 'u­ni­fy' drug dis­cov­ery and cell-line de­vel­op­ment, Ab­Sci ac­quires AI out­fit De­n­ovi­um